Navigation Links
Covance to Present at the Drug Information Association's 45th Annual Meeting
Date:6/16/2009

- Covance experts to present best practices for improving drug safety and reducing R&D time, cost -

PRINCETON, N.J., June 16 /PRNewswire-FirstCall/ -- Covance Inc. is pleased to announce the complete list of experts scheduled to present at the Drug Information Association's (DIA) 45th Annual Meeting from June 21-25, 2009 in San Diego, Calif.

The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, global, multidisciplinary event. This year's program offers learning opportunities for everyone and features the biggest names from industry, regulatory, and academia.

Building on the conference theme, "Better Medicines: Improving Safety with Every Step," Covance experts will present best practices for improving safety while reducing the time and cost of drug development, including:

June 22, 2009:

  • "Innovation at a CRO: A Strategic Management Platform to Enhance Overall Value of a Client's Portfolio"

10:30 a.m. | Speaker: Krish Ghosh, PhD, vice president, resource management

  • "Issues and Challenges Associated with the PSUR Process"

1:30 p.m. | Session Chair: Robert Bader, PharmD, senior director, product safety, periapproval services

  • "Improving Safety with Expanded Training Options for Physicians in Early Phases of Clinical Research"

1:30 p.m. | Speaker: Russ Dixon, MD, medical director, early clinical development

  • "EDC Front to Back: Streamline Processes End-to-End for True Operational Benefit"

3:30 p.m.
'/>"/>

SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Covance Elects John McCartney to Companys Board of Directors
2. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
3. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
4. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
5. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
6. Covance Purchases Equity Stake in Caprion Proteomics
7. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
8. Covance Decides to Pursue Its Original Preclinical Strategy in China
9. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
10. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
11. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/30/2015)... 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... the second $1.0M tranche under a previously awarded ... valued at up to $3.0 million to support ... as a potential medical countermeasure to mitigate acute ... awarded an initial $1.0 million under this grant ...
(Date:7/30/2015)... NH (PRWEB) , ... July 30, 2015 , ... ... homogenizer for advanced fluid applications and designed for continuous operation up to 1500 ... and sterilization-in-place, ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... 12 Varian, Inc.,(NasdaqGS: VARI) has announced that ... breadth and depth of its solutions for analytical ... a booth exhibitor at,Pittcon(R)2009. , ... information online.,And while the current economy may lead ...
... Catalyst Module Development Kit from Eurotech Presented as ... 12 Eurotech Inc., a leading provider of ... Organ Company recently received a Catalyst Module development ... Arrow Electronics. Eurotech delivers Intel Atom -based ...
... The Risk Management and Patient,Safety Institute (RM&PSI) ... calendar. The RM&PSI ( http://www.rmpsi.com ), a ... a national leader in,clinical risk management and patient ... institutions. , The spring ...
Cached Biology Technology:Varian, Inc. Announces Online Experience 2Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics 2Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics 3The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 2The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 3
(Date:7/7/2015)... Research and Markets ... the "Capacitive Fingerprint Sensors Patent Landscape" ... date, fingerprint sensing technology is the most reliable ... well developed. This patent landscape focuses on fingerprint ... domain of capacitive fingerprint sensors is closely linked ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/km7m5t/natural_language ... "Natural Language Processing Market by Type (Rule-Based, Statistical, ... Image Recognition) - Worldwide Forecast to 2020" ... vendors occupying the market are 3M, Apple, Dolbey ... Solutions, SAS Institute Inc., Verint Systems among various ...
(Date:6/30/2015)... 30, 2015 To bolster its efforts and commitment ... announced today the addition of two new team members. ... advisor and David Raviv will act as head ... Corp.,s commitment to providing the most secure solutions for the ... co-founded Layer 7 Technologies, a provider of security and management ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... and bright plumage, flamingos are a curiosity of nature. Now ... reveals an anatomical oddity that helps flamingos eat: erectile tissue. ... standing in shallow water, they bend their necks, tilt their ... from side-to-side. Their large tongue acts like a piston, sucking ...
... mice, Johns Hopkins scientists have interfered with the brain's ability ... The report, to be published in the latest issue of ... week of May 1, is based on the identification of ... body weight. , According to the researchers, the CPT1c ...
... an unfamiliar neighborhood to a friend's house or deciding ... adapting. It can make decisions based on incomplete information ... The nature of such sophisticated decision making in the ... been "poorly studied and little understood," according to Wako ...
Cached Biology News:Ohio University researchers discover evolutionary oddity in flamingos 2Eat less, weigh more? Enzyme makes lean mice 'susceptible' to dietary fat 2Eat less, weigh more? Enzyme makes lean mice 'susceptible' to dietary fat 3Where we change our mind 2
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
Anti-Human alpha2-Antiplasmin Purified (Polyclonal) (goat IgG)...
... proud to work in collaboration with Pall ... syringe filters in a variety of membrane ... for use on the Caliper TPWII, MultiDose, ... Pricing for our Automation Certified Syringe Filters ...
... TATA Binding Proteins (TBP). Ascites Antibody ITBP20 ... recognizes amino acids 41-57 and may be ... TBP occurs. This antibody does not ... as a nuclear extract or as a ...
Biology Products: